SciELO - Scientific Electronic Library Online

 
vol.21 número4Experiencia y manejo de las toxicidades en esquemas con inhibidores de transcriptasa reversa análogos de nucleósidos alternativos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

GUZMAN M, M. Antonieta; SALINAS L, Jessica; TOCHE P, Paola  y  AFANI S, Alejandro. Allergy to betalactams. Rev. chil. infectol. [online]. 2004, vol.21, n.4, pp.285-298. ISSN 0716-1018.  http://dx.doi.org/10.4067/S0716-10182004000400002.

Betalactams allergy is the first cause of drug allergy in the world. In Chile cutaneous test are performed without considering international standardizations. This review focuses in betalactam allergy diagnosis and its management. Betalactams allergic reactions can be classified according to their temporal profile, into immediate, accelerated or late reactions which coincides with symptoms and pathogenic mechanisms. Most of immediate and accelerated reactions are mediated by specific IgE, with symptoms of immediate hypersensitivity. Toxicodermies and maculo-papular exanthemas are expression of late reaction, late hypersensitivity is probably the main mechanism in the pathogenesis of these reactions. Allergens which cause immediate hypersensitivity reactions to betalactams can be major determinants (75% of the cases), minor determinants or the side chains of the suspected drugs. The study of allergic patients includes specific IgE, skin and challenge tests. The objectives of his evaluation are to detect crossed reactivities or uni-sensibilizations, and to authorize or forbid the utilization of a specific drug or its alternatives.

Palabras clave : Betalactams; Allergy; Skin test; Challenge test; Diagnosis; Management.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons